Nuclear Imaging is the branch of medical imaging that uses radioactive material to diagnose the severity of the diseases such as cancer, cardiovascular disease, gastrointestinal, endocrine, neurological disorders and other abnormalities within the body.
Nuclear imaging procedures are non-invasive and painless medical test that helps physician diagnose and evaluate medical condition.
Recently, GE Healthcare launched a new product called GENtrace, which is a small cyclotron to produce isotope fluorine-18 (F-18) which forms the base for PET tracer manufacturing. The device is easy to use, very simple, do more automated steps and could be operated by nuclear medicine technician.
It has been found that more prostate cancer has been detected by. A new molecular imaging agent was demonstrated in Society of Nuclear Medicine and Molecular Imaging (SNMMI) to find prostate cancer on tissues by locking in on the prostate specific membrane antigen (PSMA) enzyme. By this agent, one can detect prostate cancer cells that have metastasized to bone, which is a most difficult area to evaluate. The radiotracer combines with a radioactive material and an antibody called minibody. Mini-body contains anti-PSMA qualities. The radiotracer, called Zr-89 Df-IAB2M (IAB2M) imaged faster than the full antibody (J591) that targets PSMA. The particles which are emitted, detected by positron emission tomography (PET), which then creates a computerized image of the activity of the agent within the body.
Browse Full Report@ http://www.futuremarketinsights.com/reports/nuclear-imaging-devices-market
Nuclear Imaging Devices Market: Drivers & Restraints
Ageing population, increase prevalence of disease such as cancer, technological advancement, innovation, rising patient awareness, increasing healthcare expenditure, new imaging agents, increasing demand for cancer diagnostic tests, are the most important driving factors in nuclear imaging devices market. Since nuclear imaging devices has high importance in medical imaging techniques, the demand for nuclear imaging devices has increased.
With so many advantages of nuclear imaging devices, it has few disadvantages too. Insurance company lobbying to reduce unnecessary changing, reimbursement legislation, greater payer scrutiny of EMRs, loss of nuclear medicine skills, high cost of instruments, supply difficulties and cost of radiopharmaceutical, medical device excise tax are acting as a barrier nuclear imaging devices market.
Nuclear Imaging Devices Market: Segmentation
Nuclear Imaging Devices Market is broadly classified on the basis of the following segments –
- Positron Emission tomography (PET)
- Single-Photon Emission Computed Tomography (SPECT)
- Planar Scintigraphy
- Hybrid Imaging
- Infection and Inflammation
Request Report TOC@ http://www.futuremarketinsights.com/toc/rep-gb-824
Nuclear Imaging Devices Market: Overview
The nuclear imaging devices market has grown substantially at a healthy CAGR due to growing ageing population and increasing prevalence of diseases. With rapid technological advancement and innovation, nuclear imaging devices market is expected to grow globally. Asia Pacific would be the fastest growing market in the forecast period due to increase advancement in neurological applications, improving healthcare infrastructure and rapid economic growth.
Nuclear Imaging Devices Market: Region-wise Outlook
The nuclear imaging devices market is expected to register a double-digit CAGR for the forecast period. Depending on geographic regions, nuclear imaging devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America has the largest market for nuclear imaging devices and is contributing the most as compare to other regions. Asia Pacific and Japan is the fastest growing region in the forecast period for nuclear imaging devices market.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-824
Nuclear Imaging Devices Market: Key Players
Some of the key market players in nuclear imaging devices market are GE Healthcare, Philips Healthcare, Digirad, GVI Medical Devices, Siemens Healthcare, DDD-diagnostic, Nucare Medical System, Neusoft Medical System, Neurologica, SurgicEye, Shimadzu, CardiArc, CMR Naviscan.